Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen S Pieper

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Current Cardiology Reports|August 20, 2014
Challenges and solutions to pre- and post-randomization subgroup analysesManisha Desai, Karen S Pieper, Ken Mahaffey
Statistical Methods in Medical Research|June 14, 2006
Can one assess whether missing data are missing at random in medical studies?Richard F Potthoff, Gail E Tudor, Karen S Pieper, et al.
European Heart Journal|November 27, 2018
Reply to letter by Bamford et al. regarding the article: Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trialJonathan P Piccini, Jyotsna Garg, Anne Hellkamp, et al.
Biostatistics (Oxford, England)|August 28, 2010
Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trialMin Zhang, Anastasios A Tsiatis, Marie Davidian, et al.
Journal of the American Heart Association|December 16, 2015
Simplified Predictive Instrument to Rule Out Acute Coronary Syndromes in a High-Risk PopulationAlexander C Fanaroff, Ryan D Schulteis, Karen S Pieper, et al.
Journal of Interventional Cardiology|February 6, 2013
Would tirofiban have been shown non-inferior to abciximab had the TENACITY trial not been terminated for financial reasons?Peter B Berger, Judson B Williams, Vic Hasselblad, et al.
The American Journal of Medicine|July 24, 2017
Unreliable Observations from a Confounded Analysis of a Skewed DatabasePhilippe Gabriel Steg, Robert A Harrington, Anders Himmelmann, et al.
American Heart Journal|September 16, 2021
The importance of the design of observational studies in comparative effectiveness research: Lessons from the GARFIELD-AF and ORBIT-AF registriesAlfredo E Farjat, Saverio Virdone, Laine E Thomas, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 16, 2022
Two-year outcomes of UK patients newly diagnosed with atrial fibrillation: findings from the prospective observational cohort study GARFIELD-AFPatricia N Apenteng, Saverio Virdone, Fd Richard Hobbs, et al.
Clinical Cardiology|March 16, 2019
Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registryCarlos Jerjes-Sanchez, Ramon Corbalan, Antonio C P Barretto, et al.
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Current Cardiology Reports|August 20, 2014
Challenges and solutions to pre- and post-randomization subgroup analysesManisha Desai, Karen S Pieper, Ken Mahaffey
Statistical Methods in Medical Research|June 14, 2006
Can one assess whether missing data are missing at random in medical studies?Richard F Potthoff, Gail E Tudor, Karen S Pieper, et al.
European Heart Journal|November 27, 2018
Reply to letter by Bamford et al. regarding the article: Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trialJonathan P Piccini, Jyotsna Garg, Anne Hellkamp, et al.
Biostatistics (Oxford, England)|August 28, 2010
Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trialMin Zhang, Anastasios A Tsiatis, Marie Davidian, et al.
Journal of the American Heart Association|December 16, 2015
Simplified Predictive Instrument to Rule Out Acute Coronary Syndromes in a High-Risk PopulationAlexander C Fanaroff, Ryan D Schulteis, Karen S Pieper, et al.
Journal of Interventional Cardiology|February 6, 2013
Would tirofiban have been shown non-inferior to abciximab had the TENACITY trial not been terminated for financial reasons?Peter B Berger, Judson B Williams, Vic Hasselblad, et al.
The American Journal of Medicine|July 24, 2017
Unreliable Observations from a Confounded Analysis of a Skewed DatabasePhilippe Gabriel Steg, Robert A Harrington, Anders Himmelmann, et al.
American Heart Journal|September 16, 2021
The importance of the design of observational studies in comparative effectiveness research: Lessons from the GARFIELD-AF and ORBIT-AF registriesAlfredo E Farjat, Saverio Virdone, Laine E Thomas, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 16, 2022
Two-year outcomes of UK patients newly diagnosed with atrial fibrillation: findings from the prospective observational cohort study GARFIELD-AFPatricia N Apenteng, Saverio Virdone, Fd Richard Hobbs, et al.
Clinical Cardiology|March 16, 2019
Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registryCarlos Jerjes-Sanchez, Ramon Corbalan, Antonio C P Barretto, et al.
Pageof 14